Jasmine A Luzum

21PUBLICATIONS
61CO-AUTHORS
PharmacogenomicsCardiology (incl. cardiovascular diseases)Cancer geneticsGene expression (incl. microarray and other genome-wide approaches)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Aug 10, 2026
Association of the NOS1AP rs10494366 Genetic Variant With Drug-Induced QT Prolongation.

|May 06, 2026
2025 Acute Coronary Syndrome Guideline: Missing the Boat on CYP2C19 Genotyping.

|Dec 15, 2025
Understanding variation in metoprolol response: CYP2D6, drug interactions, and phenoconversion.

Bayan Azizi, David E Lanfear, Jasmine A Luzum

|Apr 26, 2025
The Beta-Blocker Pharmacogenetic Puzzle: More Pieces of Evidence for Pharmacodynamic Candidate Variants.

Jasmine A Luzum, Shana D R Littleton, Ana I Lopez-Medina

|Jul 02, 2024
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy.

Julio D Duarte, Cameron D Thomas, Craig R Lee

|Mar 20, 2024
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case-control study.

Ana I Lopez-Medina, Alessandra M Campos-Staffico, Choudhary Anwar A Chahal

Pageof 4

Frequent Collaborators

5 joint publications

Ana I Lopez-Medina

4 joint publications

David E Lanfear

3 joint publications

Alessandra M Campos-Staffico

3 joint publications

Choudhary Anwar A Chahal